The Toll of Toll-Like Receptors, Especially Toll-Like Receptor 2, on Murine Atherosclerosis

Publisher： Bentham Science Publishers

E-ISSN： 1873-5592|8|12|1230-1238

ISSN： 1389-4501

Source： Current Drug Targets, Vol.8, Iss.12, 2007-12, pp. : 1230-1238

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Essential Roles of Toll-Like Receptors in Atherosclerosis

By  

Current Medicinal Chemistry, Vol. 23, Iss. 5, 2016-02 ,pp. : 431-454

Bentham Science Publishers

Access to resources Recommend Favorite

Evaluation of Lipopeptides as Toll-like Receptor 2 Ligands

By  

Current Drug Delivery, Vol. 14, Iss. 7, 2017-10 ,pp. : 935-943

Bentham Science Publishers

Access to resources Recommend Favorite

Toll-Like Receptors and Kidney Diseases

By  

Inflammation & Allergy-Drug Targets (Formerly Current Drug Targets - Inflammation & Allergy), Vol. 8, Iss. 3, 2009-07 ,pp. : 191-201

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting Toll-like Receptors in Autoimmunity

By  

Current Drug Targets, Vol. 10, Iss. 11, 2009-11 ,pp. : 1139-1155

Bentham Science Publishers

Access to resources Recommend Favorite

Expression of Toll-like Receptor 2 and Toll-like Receptor 4 in Tuberculous Pleural Effusion

By  

Medicinal Chemistry, Vol. 13, Iss. 6, 2017-08 ,pp. : 569-576

Bentham Science Publishers

Access to resources Recommend Favorite